CIK: 1777421 - Address: C/o Intellia Therapeutics, Inc., 40 Erie Street; Suite 130, Cambridge, MA 02139
12 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/7/25 17:16
1/3/25
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSepp-Lorenzino LauraMAOEVP,ChieS-10912.180-9-1077D
1/10/24 16:15
1/8/24
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSepp-Lorenzino LauraMAOEVP,ChieS-6628.870-2-544D
1/5/24 16:50
1/3/24
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSepp-Lorenzino LauraMAOEVP,ChieS-16329.460-6-1146D
1/3/24 17:35
1/1/24
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSepp-Lorenzino LauraMAOEVP,ChieM.d00.0004752D
1/6/23 17:39
1/4/23
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSepp-Lorenzino LauraMAOEVP,ChieS.m-18337.820-5-2218D
1/4/23 20:38
1/1/23
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSepp-Lorenzino LauraMAOEVP,ChieM.d00.00041822D
3/3/22 20:03
1/1/22
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSepp-Lorenzino LauraMAOEVP,ChieM.d00.00042319D
3/3/22 20:03
1/1/22
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSepp-Lorenzino LauraMAOEVP,ChieS.d-129112.250-1-619D
9/1/21 19:34
8/30/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSepp-Lorenzino LauraMAOEVP,ChieM.d1,35914.010972D
9/1/21 19:34
8/30/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSepp-Lorenzino LauraMAOEVP,ChieS.d-15,018154.830-97-982D
8/6/21 18:19
8/4/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSepp-Lorenzino LauraMAOEVP,ChieM.d34813.400262D
8/6/21 18:19
8/4/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSepp-Lorenzino LauraMAOEVP,ChieS.d-3,594138.240-26-922D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact